Role of Stiripentol in Managing Dravet SyndromeAugust 29th 2022
Joseph E. Sullivan, MD, and Kelly Knupp, MD, evaluate the use of stiripentol in clinical practice for the management of Dravet syndrome and Mary Anne Meskis discusses the honeymoon effect of drugs.
Impact of Dravet Syndrome on QoLAugust 29th 2022
Dr Kelly Knupp, Dr Joseph E. Sullivan, and Mary Anne Meskis comment on the impact of Dravet syndrome on a patient and their caregiver’s quality of life and address education around SUDEP.
Role of Disease-Modifying Therapies for Atopic Dermatitis TreatmentAugust 29th 2022
Elizabeth A. Swanson, MD, discusses the safety and efficacy of dupilumab in treating moderate to severe atopic dermatitis, and Taylor Capps shares her journey with dupilumab from insurance approvals through receiving treatment.
Pediatric Atopic Dermatitis: Considerations and Challenges With Oral TherapiesAugust 29th 2022
Peter A. Lio, MD, describes the challenges pediatric patients face with oral therapies for atopic dermatitis, focusing on ease of administration and patient adherence.
Challenges With Available Atopic Dermatitis Treatments for Pediatric PatientsAugust 29th 2022
Raj Chovatiya, MD, PhD; Brittany G. Craiglow, MD; and Peter A. Lio, MD, highlight challenges physicians face with the available atopic dermatitis treatments for pediatric patients.
Patient Education and Future Directions for ALGS Management
Drs Ryan T. Fischer and Regino Gonzalez-Peralta provide insight on educating patients and their caregivers on emerging treatment options for Alagille syndrome and the potential impact of evolving therapies on the progression of liver disease.
Unmet Needs and Novel Agents for the Management of ALGS
Jennifer M. Vittorio, MD, and Philip Rosenthal, MD, comment on remaining challenges for the management of patients with Alagille syndrome and discuss novel therapeutic agents under investigation for disease management.
Using Maralixibat for the Management of Pediatric ALGS
Regino Gonzalez-Peralta, MD, reviews clinical implications from the phase 2 ICONIC trial evaluating the use of maralixibat for the management of Alagille syndrome in pediatric patients.
Nonpharmacological Approaches to Treat Pediatric Atopic DermatitisAugust 29th 2022
Dr Brittany G. Craiglow provides an overview of her approach to use of nonpharmacological agents in the treatment of her pediatric patients with atopic dermatitis.
Defining Treatment Success in Patients With Atopic DermatitisAugust 29th 2022
Raj Chovatiya, MD, PhD, and Brittany G. Craiglow, MD, share their opinions on how they assess and what they define as treatment success in their pediatric patients suffering from atopic dermatitis.
Pharmacologic Treatment Options for Atopic DermatitisAugust 24th 2022
Raj J. Chovatiya, MD, PhD, reviews goals of therapy for patients with atopic dermatitis and comments on the use of various topical therapies and systemic agents for disease management.
Using Multidisciplinary Care to Optimize Atopic Dermatitis TreatmentAugust 24th 2022
Korey Capozza, MPH, examines the role of multidisciplinary care for patients with atopic dermatitis, and Taylor Capps shares the impact of atopic dermatitis on mental health.